Targesome, Merck KGaA angiogenesis deal

Targesome (Palo Alto, Calif.) and Merck KGaA (Darmstadt, Germany) will combine Merck's small molecule anti-angiogenesis compounds with Targesome's nanoparticle technology to develop cancer and macular...